Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
ALHC

ALHC - Alignment Healthcare, Inc. Stock Price, Fair Value and News

6.27USD+0.02 (+0.32%)Market Closed
Watchlist

Market Summary

USD6.27+0.02
Market Closed
0.32%

ALHC Stock Price

View Fullscreen

ALHC RSI Chart

ALHC Valuation

Market Cap

1.2B

Price/Earnings (Trailing)

-7.52

Price/Sales (Trailing)

0.69

EV/EBITDA

-8.19

Price/Free Cashflow

-56.5

ALHC Price/Sales (Trailing)

ALHC Profitability

EBT Margin

-9.17%

Return on Equity

-83.66%

Return on Assets

-20.46%

Free Cashflow Yield

-1.77%

ALHC Fundamentals

ALHC Revenue

Revenue (TTM)

1.7B

Rev. Growth (Yr)

26.74%

Rev. Growth (Qtr)

-1.23%

ALHC Earnings

Earnings (TTM)

-157.7M

Earnings Growth (Yr)

12.92%

Earnings Growth (Qtr)

-23.07%

Breaking Down ALHC Revenue

Last 7 days

-1.3%

Last 30 days

-15.2%

Last 90 days

1.5%

Trailing 12 Months

-40.3%

How does ALHC drawdown profile look like?

ALHC Financial Health

Current Ratio

1.63

Debt/Equity

0.86

Debt/Cashflow

-0.13

ALHC Investor Care

Shares Dilution (1Y)

0.98%

Diluted EPS (TTM)

-0.86

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.5B1.6B1.7B0
20221.2B1.3B1.4B1.4B
20211.0B1.1B1.1B1.2B
2020807.5M858.1M908.7M959.2M
2019000757.0M

Tracking the Latest Insider Buys and Sells of Alignment Healthcare, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 07, 2024
wagner andreas p.
acquired
-
-
155,763
chief people & culture officer
Dec 21, 2023
burzacchi sebastian
acquired
-
-
125,945
coo - mgmt services org
Dec 14, 2023
margolis jeffrey h
sold
-10,152
8.46
-1,200
-
Dec 06, 2023
margolis jeffrey h
sold
-9,600
8.00
-1,200
-
Nov 10, 2023
konowiecki joseph s
sold
-28,898
5.9
-4,898
chairman of the board
Oct 16, 2023
margolis jeffrey h
sold
-48,016
8.0027
-6,000
-
Oct 04, 2023
kim hyong
acquired
-
-
340,136
chief medical officer
Sep 14, 2023
konowiecki joseph s
acquired
-
-
174,216
chairman of the board
Sep 13, 2023
joyce christopher j
sold
-80,464
5.2
-15,474
chief legal and admin. officer
Sep 06, 2023
joyce christopher j
acquired
-
-
283,308
chief legal and admin. officer

1–10 of 50

Which funds bought or sold ALHC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
reduced
-4.96
1,399,000
9,211,000
-%
Feb 15, 2024
BARCLAYS PLC
added
107
960,000
1,573,000
-%
Feb 15, 2024
Baker Avenue Asset Management, LP
sold off
-100
-500
-
-%
Feb 15, 2024
State of Wyoming
reduced
-51.25
-88,333
135,177
0.03%
Feb 15, 2024
Concorde Asset Management, LLC
reduced
-31.97
-36,575
197,858
0.14%
Feb 15, 2024
Legal & General Group Plc
added
1.39
165,570
807,575
-%
Feb 15, 2024
MERCER GLOBAL ADVISORS INC /ADV
sold off
-100
-69,000
-
-%
Feb 15, 2024
JANE STREET GROUP, LLC
new
-
936,751
936,751
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
7,568
7,568
-%
Feb 14, 2024
Point72 Middle East FZE
new
-
128,453
128,453
-%

1–10 of 49

Are Funds Buying or Selling ALHC?

Are funds buying ALHC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ALHC
No. of Funds

Unveiling Alignment Healthcare, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
t. rowe price investment management, inc.
6.4%
12,075,504
SC 13G
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Feb 13, 2023
general atlantic, l.p.
32.6%
60,993,323
SC 13G/A
Feb 10, 2023
warburg pincus private equity xii, l.p.
6.16%
11,544,243
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 14, 2022
warburg pincus private equity xii, l.p.
7.8%
14,665,604
SC 13G
Feb 11, 2022
general atlantic, l.p.
37.4%
70,069,317
SC 13G
Feb 09, 2022
fmr llc
-
0
SC 13G

Recent SEC filings of Alignment Healthcare, Inc.

View All Filings
Date Filed Form Type Document
Feb 14, 2024
SC 13G
Major Ownership Report
Feb 09, 2024
4
Insider Trading
Feb 09, 2024
SC 13G/A
Major Ownership Report
Jan 17, 2024
3
Insider Trading
Jan 08, 2024
8-K
Current Report
Dec 29, 2023
144
Notice of Insider Sale Intent
Dec 29, 2023
8-K
Current Report
Dec 28, 2023
144
Notice of Insider Sale Intent
Dec 26, 2023
144
Notice of Insider Sale Intent
Dec 22, 2023
144
Notice of Insider Sale Intent

Peers (Alternatives to Alignment Healthcare, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
487.6B
360.0B
0.01% 5.90%
22.49
1.35
14.24% 11.62%
97.1B
357.8B
0.71% -14.01%
11.63
0.27
10.95% 93.52%
83.4B
65.0B
9.34% 20.24%
15.91
1.28
7.86% -7.11%
42.9B
154.0B
-0.09% 8.25%
15.86
0.28
6.54% 124.79%
11.3B
14.0B
2.25% 10.28%
16.73
0.81
6.03% -8.61%
11.0B
12.1B
12.03% 47.11%
15.88
0.9
4.57% 23.40%
MID-CAP
9.0B
2.2B
0.13% 16.69%
36.85
4.05
4.50% -6.69%
7.8B
2.9B
-3.46% 1.96%
-425.45
2.72
13.16% -106.47%
2.1B
3.8B
-19.95% -33.62%
9.84
0.55
-27.73% -52.50%
SMALL-CAP
2.4B
1.3B
4.99% 11.37%
53.3
1.79
27.06% -27.04%
1.4B
1.0B
8.40% -11.51%
25.01
1.4
10.84% 30.19%
994.0M
3.0B
7.30% 124.36%
-5.26
0.33
6.74% 20.73%
42.1M
-
-0.60% -54.62%
-2.91
-
- -27.68%
16.9M
20.7M
- -15.62%
83.48
0.82
6.53% -85.60%

Alignment Healthcare, Inc. News

Latest updates
Simply Wall St58 minutes ago
Zacks Investment Research20 Feb 202403:20 pm

Alignment Healthcare, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue-1.2%456,709,000462,379,000439,155,000361,811,000360,348,000366,474,000345,526,000298,274,000293,466,000308,951,000267,082,000242,409,000247,867,000244,313,000224,633,000-
Operating Expenses0.1%486,465,000486,038,000471,644,000413,917,000393,758,000373,122,000382,001,000341,740,000334,916,000349,443,000319,746,000270,204,000232,807,000231,726,000229,748,000-
  S&GA Expenses18.4%83,089,00070,199,00070,408,00083,228,00076,452,00061,673,00074,293,00078,081,00076,846,00071,150,00064,914,00051,119,00038,794,00033,698,00032,787,000-
EBITDA Margin10.9%-0.07-0.08-0.07-0.08-0.08-0.09-0.12-0.14-0.13-0.08-0.040.01-0.01---
Interest Expenses3.9%5,466,0005,262,0005,019,0004,793,0004,605,0004,490,0004,401,0004,452,0004,414,0004,329,0004,248,0004,308,0004,271,0004,192,0004,160,000-
Income Taxes-100.0%-1,0001,000172,000167,000-----------
Earnings Before Taxes-23.1%-35,077,000-28,493,000-37,370,000-56,823,000-40,080,000-11,580,000-40,817,000-47,834,000-45,816,000-44,762,000-56,874,000-32,065,00010,846,0008,365,000-10,072,000-
EBT Margin8.5%-0.09-0.10-0.10-0.10-0.10-0.11-0.14-0.17-0.16-0.12-0.07-0.02-0.05---
Net Income-23.1%-35,047,000-28,477,000-37,284,000-56,903,000-40,247,000-11,580,000-40,817,000-47,834,000-45,816,000-44,762,000-56,874,000-32,065,00010,846,0008,365,000-10,072,000-
Net Income Margin8.6%-0.09-0.10-0.10-0.10-0.10-0.11-0.14-0.17-0.16-0.12-0.07-0.02-0.05---
Free Cashflow-83.9%5,992,00037,177,00085,110,000-149,263,000105,120,00010,354,000-11,638,000-30,134,00012,914,000-23,449,000-38,107,000-10,146,00026,039,000---
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Assets-1.6%771784762634778667647631657670679339302266230193
  Current Assets-2.4%667684671545692586566553577593605265---127
    Cash Equivalents-0.9%39239538441056745344946850049552820722220119286.00
  Net PPE9.6%47.0043.0040.0037.0036.0033.0032.0030.0032.0030.0028.0027.00---27.00
Liabilities1.5%581572538395505373353325332330325308299290281272
  Current Liabilities2.1%410402374230340214195167175174170153---130
  Long Term Debt0.1%162161161161161154152151149147146144---138
    LT Debt, Non Current0.1%162161161161161154152151149147146144---138
Shareholder's Equity-10.7%18921122423827229429330632534035431.0062.0051.0042.00286
  Retained Earnings-4.4%-833-798-769-732-675-635-623-582-527-481-436-379----78.71
  Additional Paid-In Capital1.3%1,0211,008992970947929917889852821791410----
Shares Outstanding0.2%189189188187187187187187187187187164----
Minority Interest-2.7%1.001.001.001.00--0.000.000.000.00------
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations-83.9%5,99237,17785,110-149,263105,12010,354-11,638-30,13412,914-23,449-38,107-10,14626,03913,487-21,819-
  Share Based Compensation-13.2%13,56915,63621,97822,88518,68712,09928,04728,81430,51130,88731,7871,144304350326-
Cashflow From Investing63.3%-9,607-26,210-110,428-8,107-8,128-5,855-6,127-2,951-6,997-6,421-4,446-4,725-4,258-3,640-3,735-
Cashflow From Financing-100.0%-30.0030.00-52717,220-100----3,529363,659-144-338-878131,484-
  Buy Backs-----------1,474144338507516-

ALHC Income Statement

2023-09-30
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:    
Earned premiums$ 450,235$ 359,978$ 1,341,924$ 1,071,450
Other6,47437016,319898
Total revenues$ 456,709$ 360,348$ 1,358,243$ 1,072,348
Revenue, Product and Service [Extensible List]us-gaap:FinancialServiceMemberus-gaap:FinancialServiceMemberus-gaap:FinancialServiceMemberus-gaap:FinancialServiceMember
Expenses:    
Medical expenses$ 397,879$ 312,850$ 1,204,838$ 923,877
Selling, general, and administrative expenses83,08976,452223,696212,418
Depreciation and amortization5,4974,45615,61312,586
Total expenses486,465393,7581,444,1471,148,881
Loss from operations(29,756)(33,410)(85,904)(76,533)
Other expenses:    
Interest expense5,4664,60515,74713,496
Other expenses (income)(145)(131)(711)252
Loss on extinguishment of debt02,19602,196
Total other expenses5,3216,67015,03615,944
Loss before income taxes(35,077)(40,080)(100,940)(92,477)
Provision for income taxes01672167
Net loss(35,077)(40,247)(100,942)(92,644)
Less: Net loss attributable to noncontrolling interest3001340
Net loss attributable to Alignment Healthcare, Inc.$ (35,047)$ (40,247)$ (100,808)$ (92,644)
Total weighted-average common shares outstanding - basic187,328,318182,123,363185,493,345180,765,300
Total weighted-average common shares outstanding - diluted187,328,318182,123,363185,493,345180,765,300
Net loss per share - basic$ (0.19)$ (0.22)$ (0.54)$ (0.51)
Net loss per share - diluted$ (0.19)$ (0.22)$ (0.54)$ (0.51)

ALHC Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current Assets:  
Cash and cash equivalents$ 391,643$ 409,549
Accounts receivable (less allowance for credit losses of $91 at September 30, 2023 and $0 at December 31, 2022, respectively)105,52392,890
Short-term investments123,9260
Prepaid expenses and other current assets45,87842,107
Total current assets666,970544,546
Property and equipment, net47,16237,169
Right of use asset, net10,4725,825
Goodwill and intangible assets, net40,10640,288
Other assets6,0826,035
Total assets770,792633,863
Current Liabilities:  
Medical expenses payable203,435170,135
Accounts payable and accrued expenses25,35631,980
Deferred premium revenue146,342308
Accrued compensation35,14127,538
Total current liabilities410,274229,961
Long-term debt, net of debt issuance costs161,595160,902
Long-term portion of lease liabilities9,3183,698
Total liabilities581,187394,561
Commitments and Contingencies (Note 12)
Stockholders' Equity:  
Preferred stock, $.001 par value; 100,000,000 and 100,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of September 30, 2023 and December 31, 202200
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 188,911,520 and 187,280,015 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively189187
Additional paid-in capital1,021,363970,180
Accumulated deficit(833,049)(732,241)
Total Alignment Healthcare, Inc. stockholders' equity188,503238,126
Noncontrolling interest1,1021,176
Total stockholders' equity189,605239,302
Total liabilities and stockholders' equity$ 770,792$ 633,863
ALHC
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, Nevada, Arizona, Florida, and Texas. The company was founded in 2013 and is based in Orange, California.
 CEO
 WEBSITEwww.alignmenthealthcare.com
 EMPLOYEES1037

Alignment Healthcare, Inc. Frequently Asked Questions


What is the ticker symbol for Alignment Healthcare, Inc.? What does ALHC stand for in stocks?

ALHC is the stock ticker symbol of Alignment Healthcare, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Alignment Healthcare, Inc. (ALHC)?

As of Fri Feb 23 2024, market cap of Alignment Healthcare, Inc. is 1.19 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ALHC stock?

You can check ALHC's fair value in chart for subscribers.

What is the fair value of ALHC stock?

You can check ALHC's fair value in chart for subscribers. The fair value of Alignment Healthcare, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Alignment Healthcare, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ALHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Alignment Healthcare, Inc. a good stock to buy?

The fair value guage provides a quick view whether ALHC is over valued or under valued. Whether Alignment Healthcare, Inc. is cheap or expensive depends on the assumptions which impact Alignment Healthcare, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ALHC.

What is Alignment Healthcare, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Feb 23 2024, ALHC's PE ratio (Price to Earnings) is -7.52 and Price to Sales (PS) ratio is 0.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ALHC PE ratio will change depending on the future growth rate expectations of investors.